- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Mori reaps $12m series A
MIT and Tufts spinout Mori, which produces food preservatives using silk proteins, welcomed back The Engine for its series A round.
Jul 21, 2020Gett parks $100m in its account
The Volkswagen and Access Industries-backed ride hailing platform closed $100m in equity, debt and bond financing at a flat $1.5bn valuation.
Jul 21, 2020Freeline progresses towards $100m IPO
The gene therapy developer has followed a $120m round co-led by Novo three weeks ago by filing to go public on the Nasdaq Global Select Market.
Jul 21, 2020Antengene accesses $97m series C
Fidelity led a series C round for haematology and cancer therapy developer Antengene, whose corporate shareholders include Celgene, Taikang, Tigermed and WuXi AppTec.
Jul 21, 2020Checkmate joins the IPO game with $75m filing
Novo-backed immuno-oncology drug developer Checkmate Pharmaceuticals has filed to go public a month after its last funding round.
Jul 21, 2020Andpad gets handed fresh funding
Salesforce Ventures returned for a $37.3m round for the construction management platform developer that was led by Globis Capital Partners.
Jul 21, 2020Openpath leads investors to $36m series C
Lincoln Property Company, Okta and Allegion helped the keyless access system developer close a round that hiked its overall funding to $63m.
Jul 21, 2020Soterea sorts out series A round
SK China has invested tens of millions of dollars in the automatic braking software provider, which will use the cash to enhance its technology and expand its market share.
Jul 20, 2020UMU interacts with TAL Education in series B
The interactive learning platform developer pulled in $14.3m through a round that followed a TAL Education-backed series A last year.
Jul 20, 2020Afresh bites into $12m series A
Maersk Growth contributed in a round bringing the fresh food monitoring technology company's overall funding to $19.8m.
Jul 20, 2020Daily deal net: July 20, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jul 20, 2020CureVac cuts $176m equity deal with GSK
GlaxoSmithKline is paying $176m for a 10% stake in University of Tübingen's RNA drug developer in connection with a strategic partnership agreement.
Jul 20, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
